Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
15817 | 690 | 44.6 | 91% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
10 | 3 | IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL | 134299 |
140 | 2 | IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY | 23462 |
15817 | 1 | PRAME//LEUKEMIA ASSOCIATED ANTIGENS//PREFERENTIALLY EXPRESSED ANTIGEN OF MELANOMA | 690 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PRAME | authKW | 1278003 | 6% | 76% | 38 |
2 | LEUKEMIA ASSOCIATED ANTIGENS | authKW | 325151 | 2% | 57% | 13 |
3 | PREFERENTIALLY EXPRESSED ANTIGEN OF MELANOMA | authKW | 265517 | 1% | 100% | 6 |
4 | PRAME ANTIGEN | authKW | 141607 | 1% | 80% | 4 |
5 | MLAA 34 | authKW | 132758 | 0% | 100% | 3 |
6 | UNIT 900 | address | 101146 | 1% | 57% | 4 |
7 | BCR ABL FUSION PEPTIDES | authKW | 88506 | 0% | 100% | 2 |
8 | BCR ABL PEPTIDES | authKW | 88506 | 0% | 100% | 2 |
9 | HAEMATOPOIET TRANSPLANTAT | address | 88506 | 0% | 100% | 2 |
10 | LEUKEMIC DENDRITIC CELLS | authKW | 88506 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 18291 | 49% | 0% | 341 |
2 | Oncology | 4645 | 43% | 0% | 295 |
3 | Immunology | 1386 | 23% | 0% | 156 |
4 | Medicine, Research & Experimental | 625 | 12% | 0% | 84 |
5 | Cell & Tissue Engineering | 304 | 2% | 0% | 14 |
6 | Cell Biology | 75 | 7% | 0% | 51 |
7 | Biotechnology & Applied Microbiology | 41 | 5% | 0% | 33 |
8 | Transplantation | 22 | 2% | 0% | 11 |
9 | Genetics & Heredity | 15 | 3% | 0% | 24 |
10 | Medical Laboratory Technology | 9 | 1% | 0% | 6 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UNIT 900 | 101146 | 1% | 57% | 4 |
2 | HAEMATOPOIET TRANSPLANTAT | 88506 | 0% | 100% | 2 |
3 | IMMUNOL TUMEURS | 74949 | 2% | 14% | 12 |
4 | SECT TRANSPLANTAT IMMUNOL | 69521 | 2% | 14% | 11 |
5 | TRANSPLANTAT IMMUNOL SECT | 59002 | 0% | 67% | 2 |
6 | STEM CELL ALLOTRANSPLANTAT SECT | 46846 | 1% | 18% | 6 |
7 | BIOL CLINU362 | 44253 | 0% | 100% | 1 |
8 | BIOMED SEVILLA IBISHEMATOL UNIT | 44253 | 0% | 100% | 1 |
9 | BLOOD DONOR ECT HE IS SECT | 44253 | 0% | 100% | 1 |
10 | BMT UNIT INTERNAL MED | 44253 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LEUKEMIA | 14634 | 7% | 1% | 50 |
2 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 12453 | 5% | 1% | 35 |
3 | LEUKEMIA RESEARCH | 7945 | 5% | 1% | 33 |
4 | BLOOD | 7601 | 11% | 0% | 77 |
5 | JOURNAL OF IMMUNOTHERAPY | 4426 | 2% | 1% | 13 |
6 | CYTOTHERAPY | 3255 | 2% | 1% | 11 |
7 | CYTOKINES CELLULAR & MOLECULAR THERAPY | 3206 | 0% | 2% | 3 |
8 | IMMUNOTHERAPY | 2998 | 1% | 1% | 7 |
9 | EXPERIMENTAL HEMATOLOGY | 2774 | 3% | 0% | 19 |
10 | BRITISH JOURNAL OF HAEMATOLOGY | 2540 | 4% | 0% | 28 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PRAME | 1278003 | 6% | 76% | 38 | Search PRAME | Search PRAME |
2 | LEUKEMIA ASSOCIATED ANTIGENS | 325151 | 2% | 57% | 13 | Search LEUKEMIA+ASSOCIATED+ANTIGENS | Search LEUKEMIA+ASSOCIATED+ANTIGENS |
3 | PREFERENTIALLY EXPRESSED ANTIGEN OF MELANOMA | 265517 | 1% | 100% | 6 | Search PREFERENTIALLY+EXPRESSED+ANTIGEN+OF+MELANOMA | Search PREFERENTIALLY+EXPRESSED+ANTIGEN+OF+MELANOMA |
4 | PRAME ANTIGEN | 141607 | 1% | 80% | 4 | Search PRAME+ANTIGEN | Search PRAME+ANTIGEN |
5 | MLAA 34 | 132758 | 0% | 100% | 3 | Search MLAA+34 | Search MLAA+34 |
6 | BCR ABL FUSION PEPTIDES | 88506 | 0% | 100% | 2 | Search BCR+ABL+FUSION+PEPTIDES | Search BCR+ABL+FUSION+PEPTIDES |
7 | BCR ABL PEPTIDES | 88506 | 0% | 100% | 2 | Search BCR+ABL+PEPTIDES | Search BCR+ABL+PEPTIDES |
8 | LEUKEMIC DENDRITIC CELLS | 88506 | 0% | 100% | 2 | Search LEUKEMIC+DENDRITIC+CELLS | Search LEUKEMIC+DENDRITIC+CELLS |
9 | PREFERENTIALLY EXPRESSED ANTIGEN OF MELANOMA PRAME | 88506 | 0% | 100% | 2 | Search PREFERENTIALLY+EXPRESSED+ANTIGEN+OF+MELANOMA+PRAME | Search PREFERENTIALLY+EXPRESSED+ANTIGEN+OF+MELANOMA+PRAME |
10 | CML28 | 79653 | 0% | 60% | 3 | Search CML28 | Search CML28 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | HERMES, N , KEWITZ, S , STAEGE, MS , (2016) PREFERENTIALLY EXPRESSED ANTIGEN IN MELANOMA (PRAME) AND THE PRAME FAMILY OF LEUCINE-RICH REPEAT PROTEINS.CURRENT CANCER DRUG TARGETS. VOL. 16. ISSUE 5. P. 400 -414 | 79 | 45% | 1 |
2 | PINILLA-IBARZ, J , SHAH, B , DUBOVSKY, JA , (2009) THE BIOLOGICAL BASIS FOR IMMUNOTHERAPY IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA.CANCER CONTROL. VOL. 16. ISSUE 2. P. 141 -152 | 70 | 53% | 7 |
3 | VONKA, V , (2010) IMMUNOTHERAPY OF CHRONIC MYELOID LEUKEMIA: PRESENT STATE AND FUTURE PROSPECTS.IMMUNOTHERAPY. VOL. 2. ISSUE 2. P. 227 -241 | 57 | 53% | 5 |
4 | RUSAKIEWICZ, S , MADRIGAL, A , TRAVERS, P , DODI, AI , (2009) BCR/ABL-SPECIFIC CD8(+) T CELLS CAN BE DETECTED FROM CML PATIENTS, BUT ARE ONLY EXPANDED FROM HEALTHY DONORS.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 58. ISSUE 9. P. 1449 -1457 | 29 | 94% | 7 |
5 | WESTERMANN, J , KOPP, J , VAN LESSEN, A , HECKER, AC , BASKAYNAK, G , LE COUTRE, P , DOHNER, K , DOHNER, H , DORKEN, B , PEZZUTTO, A , (2007) VACCINATION WITH AUTOLOGOUS NON-IRRADIATED DENDRITIC CELLS IN PATIENTS WITH BCR/ABL PLUS CHRONIC MYELOID LEUKAEMIA.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 137. ISSUE 4. P. 297-306 | 28 | 82% | 20 |
6 | ABDELMALAK, CA , YAHYA, RS , ELGHANNAM, DM , EL-KHADRAGY, AE , ABD EL MESSIH, HM , (2014) PRAME GENE EXPRESSION IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: IMPACT ON PROGNOSIS.CLINICAL LABORATORY. VOL. 60. ISSUE 1. P. 55 -61 | 22 | 81% | 6 |
7 | WESTERS, TM , OSSENKOPPELE, GJ , VAN DE LOOSDRECHT, AA , (2007) DENDRITIC CELL-BASED IMMUNOTHERAPY IN ACUTE AND CHRONIC MYELOID LEUKAEMIA.BIOMEDICINE & PHARMACOTHERAPY. VOL. 61. ISSUE 6. P. 306 -314 | 41 | 53% | 5 |
8 | WADELIN, F , FULTON, J , MCEWAN, PA , SPRIGGS, KA , EMSLEY, J , HEERY, DM , (2010) LEUCINE-RICH REPEAT PROTEIN PRAME: EXPRESSION, POTENTIAL FUNCTIONS AND CLINICAL IMPLICATIONS FOR LEUKAEMIA.MOLECULAR CANCER. VOL. 9. ISSUE . P. - | 34 | 54% | 15 |
9 | VONKA, V , PETRACKOVA, M , (2015) IMMUNOLOGY OF CHRONIC MYELOID LEUKEMIA: CURRENT CONCEPTS AND FUTURE GOALS.EXPERT REVIEW OF CLINICAL IMMUNOLOGY. VOL. 11. ISSUE 4. P. 511 -522 | 37 | 45% | 0 |
10 | BRAYER, JB , PINILLA-IBARZ, J , (2013) DEVELOPING STRATEGIES IN THE IMMUNOTHERAPY OF LEUKEMIAS.CANCER CONTROL. VOL. 20. ISSUE 1. P. 49 -59 | 41 | 40% | 6 |
Classes with closest relation at Level 1 |